Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.
Leiomyoma
PROCEDURE: Interventional radiological or surgical management
quality of life, 1,3,5,10 year.|pregnant, 3 years
tumor recurrence, 1,3,5,10 years|complications, 3,6,12,24 months|ovarian functions, 3,6,12 months, 2,3,5 and 10 years|symptom relief, 3,6,12,24 months|tumour volume, 3,6,12 18 24 months and 3,5,10 years
The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.